Exploring the role of ctDNA in triple negative breast cancer

被引：0
|
作者：
den Brok, W. D.
Kong, E.
Bates, C.
Aguirre-Hernandez, R.
Miller, R. R.
Lum, A.
Wan, A.
Shah, S.
Aparicio, S.
Gelmon, K. A.
机构：
[1] BC Canc, Vancouver, BC, Canada
[2] BC Canc Res Ctr, Vancouver, BC, Canada
[3] Contextual Genom Inc, Vancouver, BC, Canada
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-P3-08-13
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-08-13
引用
收藏
页数：2
相关论文
共 50 条
  • [21] THE ROLE OF IMMUNOTHERAPY IN THE TREATMENT OF TRIPLE NEGATIVE BREAST CANCER (TNBC)
    Rugo, Hope S.
    BREAST, 2017, 36 : S29 - S30
  • [22] The role of histology on survival of triple negative breast cancer.
    Parise, Carol
    Caggiano, Vincent
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [23] The paradoxical role of RalA and RalB in triple negative breast cancer
    Spehar, Jonathan M.
    Thies, Katie A.
    Cole, Matthew W.
    Schafer, Rachel E.
    Richardson, Dillon S.
    Steck, Sarah A.
    Das, Manjusri
    Lian, Arthur W.
    Ray, Alo
    Knoblaugh, Sue E.
    Trimmers, Cynthia D.
    Sizemore, Gina M.
    Sizemore, Steven T.
    CANCER RESEARCH, 2022, 82 (04)
  • [24] Role of flavonoids in inhibiting triple-negative breast cancer
    Wang, Shuai
    Wang, Kuanyu
    Li, Cheng
    Chen, Jing
    Kong, Xiangding
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [25] Role of CD47 in triple negative breast cancer
    Kaur, Sukhbir
    Singh, Satya
    Elkahloun, Abdel
    Wu, Weiwei
    Song, Tim
    Arora, Ashi
    Roberts, David
    FASEB JOURNAL, 2015, 29
  • [26] Triple-Negative Breast Cancer Role of Antiangiogenic Agents
    Greenberg, Sally
    Rugo, Hope S.
    CANCER JOURNAL, 2010, 16 (01): : 33 - 38
  • [27] The Role of Body Mass Index in Triple Negative Breast Cancer
    Cakar, Burcu
    Muslu, Ugur
    Erdogan, Atike P.
    Ozisik, Melih
    Ozisik, Hatice
    Dalgic, Ceyda Tunakan
    Durusoy, Raika
    Karaca, Burcak
    Sezgin, Canfeza
    Karabulut, Bulent
    Uslu, Ruchan
    ONCOLOGY RESEARCH AND TREATMENT, 2015, 38 (10) : 518 - 522
  • [28] Characterizing the role of Filopodia in Triple Negative Breast Cancer (TNBC).
    Lanns, D.
    Dalton, J.
    Galli, L. M.
    Burrus, L. W.
    MOLECULAR BIOLOGY OF THE CELL, 2018, 29 (26)
  • [29] The Role of Immunotherapy in Triple-Negative Breast Cancer (TNBC)
    Michaels, Elena
    Chen, Nan
    Nanda, Rita
    CLINICAL BREAST CANCER, 2024, 24 (04) : 263 - 270
  • [30] Triple-Negative Breast Cancer Role of the Androgen Receptor
    Gucalp, Ayca
    Traina, Tiffany A.
    CANCER JOURNAL, 2010, 16 (01): : 62 - 65
12345